Report Highlights
The global market for blood testing will grow from nearly $53.8 billion in 2018 to $60.5 billion by 2023 with a compound annual growth rate (CAGR) of 2.4% for the period of 2018-2023.
Report Includes
- 35 data tables and 43 additional tables
- Country specific data and analysis for US, Canada, Mexico, Germany, France, UK, Italy, Spain, Portugal, China, India, Japan, South Korea and Australia
- Analysis of the global market for blood testing, using quantitative and qualitative approaches
- Description of blood tests that are routinely used for evaluating, screening and monitoring by using analysers (including automated analysers) and integrated systems
- Coverage of methods of extraction of blood for blood testing, and discussion of advantages and disadvantages of blood tests
- Detailed study of the regulatory and reimbursement aspect of the industry
- Insight into current trends and recent developments in the blood testing market
- Comprehensive company profiles of major players in the industry, including Abbott Laboratories, Biomérieux Marcy L’etoile, F. Hoffman-La Roche Ag, Nova Biomedical Corp., Siemens Healthineers, Thermo Fisher Scientific
Report Scope
This study covers the blood tests that are used routinely for screening, monitoring and evaluating by using analyzers (including automated analyzers) and integrated systems. This report also covers home-monitoring devices and test strips and the associated calibration reagents for diabetes and lipid profiles using finger pricks. The report analyzes and assesses therapeutic and screening applications of blood tests for human conditions such as diabetes, heart disease, autoimmune disorders, cancer, blood disorders, hormonal imbalances, infection and pregnancy. Excluded from this study are urinalysis, urine home diagnostic kits and diagnostic testing such as imaging as well as veterinary blood tests and their analyzers.
The report also includes a discussion of the market’s major drivers and global dynamics along with the political, economic, social and technological factors that impact the market. The report provides market size estimates for the year 2017 (considered as a base year) and 2018, as well as a forecast through 2023. Market estimates and forecast figures are provided for all major market segments. A discussion of the major players is included in the competitive landscape section, which provides trends in product launches, collaborations, mergers and acquisitions, and other agreements.
The report concludes with a special focus on company profiles and includes detailed profiles of the major vendors in the blood testing market.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
- Metal-organic Frameworks: Global Markets (AVM200B)
- Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets (PHM204C)
- Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
- Surgical Equipment: Technologies and Global Markets (HLC154C)
Report Highlights
The blood testing market totaled $49.5 billion in 2013 and reached to nearly $50 billion in 2014 This market is expected to grow $56.6 billion in 2019, with a compound annual growth rate (CAGR) of 2.6%.
Report Includes
- An overview of the global markets and technologies for blood testing.
- Analyses of global market trends, with data from 2012, 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
- Coverage of major blood test categories including hematology, molecular screening, toxicology, and also oncology biomarker tests and cardiology tests.
- Information on the latest trends and innovations in the blood testing product pipeline as well as information on new approaches for screening.
- Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
- Relevant patent analysis.
- Profiles of major players in the blood testing market.
Related Reports
Antibody-Drug Conjugates: Technologies and Global Markets
The global market for antibody-drug conjugates is estimated to increase from $10.8 billion in 2023 to reach $47.0 billion by 2029, at a compound annual growth rate (CAGR) of 28.4% from 2024 through 2029.
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.
Hemoglobin A1c Testing Devices and Kits Market
The global market for hemoglobin A1c testing devices and kits is estimated to increase from $2.1 billion in 2023 to reach $3.2 billion by 2028, at a compound annual growth rate (CAGR) of 9.2% from 2023 through 2028.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More